NCT05573373 2024-01-31
Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer
Affiliated Hospital of Jiangnan University
Phase 1 Unknown
Clinical Trials
12 trialsNCT03882580 2023-04-24
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
Unknown
NCT05728788 2023-03-03
Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy
Peking University Third Hospital
Unknown
NCT05486988 2022-08-04
ctDNA as a Biomarker for Treatment in Advanced NSCLC
Fuzhou General Hospital
Unknown
NCT04943029 2021-09-02
NEOSUN
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT04696250 2021-01-06
AVATAR
University Hospital, Caen
Unknown
NCT04663438 2020-12-11
Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC
Peking Union Medical College Hospital
Unknown
NCT04115410 2020-05-28
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Sungkyunkwan University
Unknown
NCT03923036 2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
NCT03799679 2019-01-10
Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer
Fudan University
Phase 4 Unknown
NCT03777930 2018-12-19
The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol
Shenzhen Fifth People's Hospital
Phase 4 Unknown
NCT03611179 2018-08-02
Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer
Assiut University
Phase 2 Unknown